HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Oncorus (NASDAQ:ONCR) from Buy to Neutral.
GeForce RTX 4060: How Nvidia’s AI Investments Elevate Gaming Performance
Nvidia Corp's (NASDAQ: NVDA) launch of the
HC Wainwright & Co. Downgrades Oncorus to Neutral
HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Oncorus (NASDAQ:ONCR) from Buy to Neutral.
Related Posts
Nasdaq Turns Higher; Delta Air Lines Earnings Miss Estimates
U.S. stocks pared some losses midway through trading, with the Nasdaq Composite turning higher on Wednesday. The annual inflation rate in the US increased to 9.1% in June, the highest level since November 1981.
The Analyst Verdict: Gilead Sciences In The Eyes Of 12 Experts
In the last three months, 12 analysts have published ratings on Gilead Sciences (NASDAQ:GILD), offering a diverse range…
Expert Ratings For Sunoco
Analysts’ ratings for Sunoco (NYSE:SUN) over the last quarter vary from bullish to bearish, as provided by 6…